XML 33 R62.htm IDEA: XBRL DOCUMENT
v3.2.0.727

Segment Information (Schedule of Segment Information) (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended |
--- | --- | --- | ---
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | Dec. 31, 2014
Segment sales | $ 8,660 |  | $ 9,783 |  | $ 17,901 |  | $ 19,992 |  |
Less: Transfers | 65 |  | 77 |  | 134 |  | 158 |  |
Net sales | 8,595 |  | 9,706 |  | 17,767 |  | 19,834 |  |
PTOI | 1,637 |  | 1,955 |  | 3,578 |  | 4,203 |  |
Agriculture [Member] |  |  |  |  |  |  |  |  |
Segment sales | 3,218 |  | 3,615 |  | 7,155 |  | 8,009 |  |
Less: Transfers | 0 |  | 5 |  | 0 |  | 8 |  |
Net sales | 3,218 |  | 3,610 |  | 7,155 |  | 8,001 |  |
PTOI | 774 | [1] | 789 | [2] | 1,948 | [1],[3] | 2,231 | [2] |
Segment net assets | 10,246 |  |  |  | 10,246 |  |  |  | $ 6,695
Increase in net assets |  |  |  |  | 3,551 |  |  |  |
Electronics & Communications [Member] |  |  |  |  |  |  |  |  |
Segment sales | 534 |  | 617 |  | 1,055 |  | 1,197 |  |
Less: Transfers | 6 |  | 4 |  | 10 |  | 7 |  |
Net sales | 528 |  | 613 |  | 1,045 |  | 1,190 |  |
PTOI | 104 | [1] | 21 | [2] | 189 | [1] | 96 | [2] |
Industrial Biosciences [Member] |  |  |  |  |  |  |  |  |
Segment sales | 288 |  | 317 |  | 573 |  | 618 |  |
Less: Transfers | 3 |  | 4 |  | 8 |  | 7 |  |
Net sales | 285 |  | 313 |  | 565 |  | 611 |  |
PTOI | 49 | [1] | 57 | [2] | 105 | [1] | 113 | [2] |
Nutrition & Health [Member] |  |  |  |  |  |  |  |  |
Segment sales | 826 |  | 926 |  | 1,639 |  | 1,787 |  |
Less: Transfers | 0 |  | 0 |  | 0 |  | 0 |  |
Net sales | 826 |  | 926 |  | 1,639 |  | 1,787 |  |
PTOI | 99 | [1] | 97 | [2] | 188 | [1] | 190 | [2] |
Performance Chemicals [Member] |  |  |  |  |  |  |  |  |
Segment sales | 1,502 |  | 1,696 |  | 2,866 |  | 3,287 |  |
Less: Transfers | 28 |  | 48 |  | 57 |  | 105 |  |
Net sales | 1,474 |  | 1,648 |  | 2,809 |  | 3,182 |  |
PTOI | 54 | [1],[4] | 232 | [2] | 183 | [1],[4] | 438 | [2] |
Performance Materials [Member] |  |  |  |  |  |  |  |  |
Segment sales | 1,365 |  | 1,582 |  | 2,776 |  | 3,116 |  |
Less: Transfers | 27 |  | 15 |  | 57 |  | 29 |  |
Net sales | 1,338 |  | 1,567 |  | 2,719 |  | 3,087 |  |
PTOI | 309 | [1] | 665 | [2],[5] | 636 | [1] | 958 | [2],[5] |
Safety & Protection [Member] |  |  |  |  |  |  |  |  |
Segment sales | 925 |  | 1,029 |  | 1,834 |  | 1,976 |  |
Less: Transfers | 1 |  | 1 |  | 2 |  | 2 |  |
Net sales | 924 |  | 1,028 |  | 1,832 |  | 1,974 |  |
PTOI | 308 | [1],[6] | 178 | [2] | 492 | [1],[6] | 353 | [2] |
Gain related to litigation settlement |  |  |  |  | 112 |  |  |  |
Other Segment [Member] |  |  |  |  |  |  |  |  |
Segment sales | 2 |  | 1 |  | 3 |  | 2 |  |
Less: Transfers | 0 |  | 0 |  | 0 |  | 0 |  |
Net sales | 2 |  | 1 |  | 3 |  | 2 |  |
PTOI | (60) |  | (84) | [2] | (163) | [7] | (176) | [2] |
Imprelis [Member] |  |  |  |  |  |  |  |  |
Insurance recoveries for litigation |  |  |  |  | 35 |  |  |  |
Imprelis [Member] | Agriculture [Member] |  |  |  |  |  |  |  |  |
Insurance recoveries for litigation |  |  |  |  | 35 |  |  |  |
Cost basis investment impairment [Member] |  |  |  |  |  |  |  |  |
Cost basis investment impairment |  |  |  |  | (37) |  |  |  |
Cost basis investment impairment [Member] | Other Segment [Member] |  |  |  |  |  |  |  |  |
Cost basis investment impairment |  |  |  |  | (37) |  |  |  |
2014 Restructuring Program [Member] |  |  |  |  |  |  |  |  |
Restructuring reserve, accrual adjustment |  |  |  |  | 0 |  |  |  |
Restructuring charges |  |  | (263) |  |  |  | (206) |  |
2014 Restructuring Program [Member] | Agriculture [Member] |  |  |  |  |  |  |  |  |
Restructuring reserve, accrual adjustment | (4) |  |  |  | (4) |  |  |  |
Restructuring charges |  |  | (47) |  |  |  | (47) |  |
2014 Restructuring Program [Member] | Electronics & Communications [Member] |  |  |  |  |  |  |  |  |
Restructuring reserve, accrual adjustment | 11 |  |  |  | 11 |  |  |  |
Restructuring charges |  |  | (68) |  |  |  | (68) |  |
2014 Restructuring Program [Member] | Industrial Biosciences [Member] |  |  |  |  |  |  |  |  |
Restructuring reserve, accrual adjustment | (1) |  |  |  | (1) |  |  |  |
Restructuring charges |  |  | (2) |  |  |  | (2) |  |
2014 Restructuring Program [Member] | Nutrition & Health [Member] |  |  |  |  |  |  |  |  |
Restructuring reserve, accrual adjustment | (4) |  |  |  | (4) |  |  |  |
Restructuring charges |  |  | (8) |  |  |  | (8) |  |
2014 Restructuring Program [Member] | Performance Chemicals [Member] |  |  |  |  |  |  |  |  |
Restructuring reserve, accrual adjustment | 2 |  |  |  | 2 |  |  |  |
Restructuring charges |  |  | (19) |  |  |  | (19) |  |
2014 Restructuring Program [Member] | Performance Materials [Member] |  |  |  |  |  |  |  |  |
Restructuring reserve, accrual adjustment | (2) |  |  |  | (2) |  |  |  |
Restructuring charges |  |  | (29) |  |  |  | (29) |  |
2014 Restructuring Program [Member] | Safety & Protection [Member] |  |  |  |  |  |  |  |  |
Restructuring reserve, accrual adjustment | 1 |  |  |  | 1 |  |  |  |
Restructuring charges |  |  | (31) |  |  |  | (31) |  |
2014 Restructuring Program [Member] | Other Segment [Member] |  |  |  |  |  |  |  |  |
Restructuring reserve, accrual adjustment | (3) |  |  |  | $ (3) |  |  |  |
Restructuring charges |  |  | $ (2) |  |  |  | (2) |  |
Chemours Restructuring Program [Member] |  |  |  |  |  |  |  |  |
Restructuring charges | (61) |  |  |  |  |  |  |  |
Chemours Restructuring Program [Member] | Performance Chemicals [Member] |  |  |  |  |  |  |  |  |
Restructuring charges | $ (61) |  |  |  |  |  |  |  |
GLS/Vinyls [Member] |  |  |  |  |  |  |  |  |
Pre-tax gain |  |  |  |  |  |  | 391 |  |
GLS/Vinyls [Member] | Performance Materials [Member] |  |  |  |  |  |  |  |  |
Pre-tax gain |  |  |  |  |  |  | $ 391 |  |
[1] | Included adjustments to the estimated costs associated with the 2014 restructuring program, recorded in employee separation / asset related charges, net. These adjustments were primarily due to lower than estimated individual severance costs and workforce reductions achieved through non-severance programs, partially offset by identification of additional projects in certain segments. There was no impact from these adjustments to the company's interim Consolidated Income Statements. The adjustments impacted segment results for the three months ended June 30, 2015 as follows: Agriculture - $(4) , Electronics & Communications - $11, Industrial Biosciences - $(1), Nutrition & Health - $(4), Performance Chemicals - $2, Performance Materials - $(2), and Safety & Protection $1, and Other - $(3). See Note 3 for additional information.
[2] | Included a $(206) restructuring charge recorded in employee separation / asset related charges, net. The pre-tax charges by segment are: Agriculture - $(47) , Electronics & Communications - $(68) , Industrial Biosciences - $(2) , Nutrition & Health - $(8) , Performance Chemicals - $(19) , Performance Materials - $(29) , Safety & Protection - $(31), and Other - $(2). See Note 3 for additional information.
[3] | Included $35 of insurance recoveries recorded in other operating charges for recovery of costs for customer claims related to the use of the Imprelis® herbicide. See Note 10 for additional information.
[4] | Included a $(61) restructuring charge recorded in employee separation / asset related charges, net, consisting of severance and related benefit costs in the Performance Chemicals segment to achieve fixed cost and operational productivity improvements for Chemours post-separation. See Note 3 for additional information.
[5] | Included a gain of $391 recorded in other income, net associated with the sale of GLS/Vinyls. See Note 2 for additional information.
[6] | Included a gain of $112, net of legal expenses, recorded in other income, net related to the company’s settlement of a legal claim.
[7] | Included a $(37) pre-tax impairment charge recorded in employee separation / asset related charges, net for a cost basis investment. See Note 3 for additional information.

X
- Definition Insurance recoveries for litigation. + References No definition available. + Details
Name: | dd_InsuranceRecoveriesforLitigation
Namespace Prefix: | dd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Segment Net Assets Increase Decrease + References No definition available. + Details
Name: | dd_SegmentNetAssetsIncreaseDecrease
Namespace Prefix: | dd_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of net assets (liabilities). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 225 -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09.6,7) -URI http://asc.fasb.org/extlink&oid=6488393&loc=d3e606914-122999 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 30 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35686370&loc=SL35686385-199418 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 210 -Section S99 -Paragraph 2 -Subparagraph (SX 210.6-05.4) -URI http://asc.fasb.org/extlink&oid=6488278&loc=d3e604008-122996 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 05 -Paragraph 4 -Article 6 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 09 -Paragraph 19 -Article 6 + Details
Name: | us-gaap_AssetsNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the cost method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 325 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6872867&loc=d3e40691-111596 + Details
Name: | us-gaap_CostmethodInvestmentsOtherThanTemporaryImpairment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The gain (loss) resulting from the sale of a disposal group that is not a discontinued operation. It is included in income from continuing operations before income taxes in the income statement. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=8077374&loc=d3e2443-110228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 + Details
Name: | us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349 + Details
Name: | us-gaap_GainLossRelatedToLitigationSettlement
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.P.4(b)) -URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section P -Subsection 3, 4 + Details
Name: | us-gaap_RestructuringAndRelatedCostIncurredCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of any reversal and other adjustment made during the period to the amount of a previously accrued liability for a specified type of restructuring cost, excluding adjustments for costs incurred during the period, costs settled during the period, and foreign currency translation adjustments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 40 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6394291&loc=d3e17658-110867 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.P.4(b)) -URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section P -Subsection 3, 4 + Details
Name: | us-gaap_RestructuringReserveAccrualAdjustment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(e)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Related Parties -URI http://asc.fasb.org/extlink&oid=16382449 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07.1(c)) -URI http://asc.fasb.org/extlink&oid=6488393&loc=d3e606610-122999 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 07 -Paragraph b -Subparagraph 1 -Article 6 + Details
Name: | us-gaap_RevenueFromRelatedParties
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 + Details
Name: | us-gaap_SalesRevenueNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dd_AgricultureMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dd_ElectronicsCommunicationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dd_IndustrialBiosciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dd_NutritionHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dd_PerformanceChemicalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dd_PerformanceMaterialsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dd_SafetyProtectionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dd_OtherSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=dd_ImprelisMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementScenarioAxis=dd_CostbasisinvestmentimpairmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringPlanAxis=dd_A2014RestructuringProgramMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RestructuringPlanAxis=dd_ChemoursRestructuringProgramMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dd_DivestituresandOtherTransactionsAxis=dd_GLSVinylsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |